A Pharmacokinetic Study of TS-142 in Patients with Hepatic Impairment

Clinical trial NCT05624944 · COMPLETED

Trial details

NCT number: NCT05624944
Sponsor: Taisho Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Patients with Mild or Moderate Hepatic Impairment

Start date: 2022-12-26
Primary completion: 2023-12-05
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.